GlassScriptPhysician profile
Robert P Bonitz
NPI 1104182716
$9,791.99
in general payments reported to CMS, 2019-2025
47 companies · $2,802 in 2025
The $2,802 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $595 · 2021: $792 · 2022: $1,576 · 2023: $2,042 · 2024: $1,569 · 2025: $2,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,408 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,408.14 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,014.68 | 2020-2025 | Lithovue, Axonics, General - Erectile Dysfunction |
| Davol INC. | $980.41 | 2019-2024 | Arista Ah Flexitip, Phasix Mesh |
| Integra Lifesciences Corporation | $885.58 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Dendreon Pharmaceuticals LLC | $710.76 | 2019-2025 | Provenge |
| Coloplast Corp | $499.17 | 2019-2025 | Speedicath |
| Astellas Pharma US INC | $463.80 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $428.50 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $388.60 | 2019-2025 | |
| Antares Pharma, INC. | $347.40 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Urogen Pharma, INC. | $293.66 | 2021-2025 | Jelmyto |
| 180 Medical, INC. | $256.55 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $241.29 | 2023-2025 | Prolaris, Myrisk |
| Abbvie INC. | $237.77 | 2022-2025 | Botox |
| Edap Technomed INC | $198.08 | 2025 | |
| Baxter Healthcare | $195.06 | 2024-2025 | Tisseel, Floseal, Perclot |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $192.11 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $183.96 | 2024-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $181.54 | 2019-2024 | Xiaflex |
| Royal Biologics, INC. | $179.27 | 2025 | |
| Procept Biorobotics Corporation | $150.45 | 2024 | Aquabeam System |
| Tolmar, INC. | $150.07 | 2023-2025 | Eligard |
| Immunitybio, INC. | $131.96 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $131.52 | 2022-2025 | Keytruda, Lynparza |
| Myovant Sciences INC. | $112.47 | 2021-2022 | |
| Janssen Biotech, INC. | $99.02 | 2023-2025 | Erleada |
| Endo USA, INC. | $89.76 | 2024-2025 | Xiaflex, Aveed |
| Telix Pharmaceuticals | $84.49 | 2024-2025 | Illuccix |
| Medtronic USA, INC. | $84.01 | 2019-2020 | |
| Dentsply Ih Ab | $81.22 | 2023-2025 | Lofric, Lofric |
| Verity Pharmaceuticals INC. | $70.89 | 2025 | Trelstar, Tlando |
| Progenics Pharmaceuticals, INC. | $70.23 | 2023-2025 | Pylarify |
| Urovant Sciences INC | $70.21 | 2022 | |
| Blue Earth Diagnostics | $63.91 | 2019-2025 | Posluma |
| Bayer Healthcare Pharmaceuticals INC. | $63.39 | 2023-2025 | |
| Becton, Dickinson and Company | $59.21 | 2022 | |
| Halozyme INC | $58.70 | 2023 | |
| Novartis Pharmaceuticals Corporation | $55.20 | 2025 | |
| Olympus America INC. | $44.20 | 2022-2024 | Bovie |
| Accord Healthcare, INC. | $38.51 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $36.36 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter, Urgent PC Neuromodulation System |
| Axonics, INC. | $35.21 | 2023 | Axonics |
| Teleflex LLC | $33.44 | 2024-2025 | Urolift |
| Allergan, INC. | $25.22 | 2019 | |
| Rochester Medical Corporation | $24.66 | 2022 | |
| Photocure INC | $19.54 | 2025 | Cysview |
| Hollister Incorporated | $16.41 | 2023 | Infyna Chic |
| Sun Pharmaceutical Industries INC. | $13.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bonitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.